Involvement of advanced glycation end product-induced asymmetric dimethylarginine generation in endothelial dysfunction. (Q50908119)

25 March 2018

title

Involvement of advanced glycation end product-induced asymmetric dimethylarginine generation in endothelial dysfunction. (English)

1 reference

25 March 2018

0 references

Ryotaro Ando

1

1 reference

25 March 2018

Seiji Ueda

2

1 reference

25 March 2018

Sho-ichi Yamagishi

3

1 reference

25 March 2018

Hiroshi Miyazaki

4

1 reference

25 March 2018

Yusuke Kaida

5

1 reference

25 March 2018

Kumiko Kaifu

6

1 reference

25 March 2018

Miyuki Yokoro

7

1 reference

25 March 2018

Yosuke Nakayama

8

1 reference

25 March 2018

Nana Obara

9

1 reference

25 March 2018

Kei Fukami

10

1 reference

25 March 2018

Masayoshi Takeuchi

11

1 reference

25 March 2018

Seiya Okuda

12

1 reference

25 March 2018

language of work or name

English

0 references

publication date

13 June 2013

1 reference

25 March 2018

Diabetes and Vascular Disease Research

published in

1 reference

25 March 2018

volume

10

1 reference

25 March 2018

page(s)

436-441

1 reference

25 March 2018

issue

5

1 reference

25 March 2018

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1479164113486662

Advanced glycosylation: chemistry, biology, and implications for diabetes and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113486662

Advanced glycosylation end products in patients with diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113486662

Receptor for advanced glycation end products (RAGE): a novel therapeutic target for diabetic vascular complication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113486662

RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113486662

Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113486662

Nitric oxide deficiency in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113486662

The L-arginine-nitric oxide pathway: role in atherosclerosis and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113486662

Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113486662

Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113486662

AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113486662

Ambient pressure stimulates immortalized human aortic endothelial cells to increase DNA synthesis and matrix metalloproteinase 1 (tissue collagenase) production

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113486662

Pigment epithelium-derived factor prevents advanced glycation end products-induced monocyte chemoattractant protein-1 production in microvascular endothelial cells by suppressing intracellular reactive oxygen species generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113486662

Positive association of serum levels of advanced glycation end products and high mobility group box-1 with asymmetric dimethylarginine in nondiabetic chronic kidney disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113486662

Advanced glycation end products and endothelial dysfunction in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113486662

Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113486662

Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113486662

Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113486662

Ex vivo gene transferring of human dimethylarginine dimethylaminohydrolase-2 improved endothelial dysfunction in diabetic rat aortas and high glucose-treated endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113486662

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113486662

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113486662

Vascular endothelial-specific dimethylarginine dimethylaminohydrolase-1-deficient mice reveal that vascular endothelium plays an important role in removing asymmetric dimethylarginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113486662

N(epsilon)-(carboxymethyl)lysine levels in patients with type 2 diabetes: role of renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113486662

Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164113486662

21 January 2018

Identifiers

DOI

10.1177/1479164113486662

1 reference

25 March 2018

PubMed ID

23766377

1 reference

25 March 2018